Demant
Demant is a Danish-founded (1904) global hearing healthcare group operating hearing aids (Oticon, Bernafon, Sonic), hearing care clinics (Audika), and diagnostic instruments (Interacoustics, Maico) across 130+ countries, serving hearing-impaired consumers and audiology professionals with AI-powered solutions.
- Company typePublic
- Founded1904
- HeadquartersSmørumnedre, Denmark
- Headcount11–50
- GTM typeB2B and B2C
- OfferingHardware or Manufacturing
What Demant does
Demant A/S is a Denmark-founded (1904) global hearing healthcare and audio technology group listed on Nasdaq Copenhagen, operating three business areas: Hearing Aids (Oticon, Bernafon, Sonic brands plus Philips-branded solutions), Hearing Care (Audika clinic network with 5,000+ specialists across nearly 30 countries), and Diagnostics (Interacoustics and Maico instruments). The company develops, manufactures, and sells hearing aids, diagnostic audiological equipment, and hearing care services in over 130 countries, generating DKK 22,971 million in FY2025 revenue from a workforce of more than 26,000. Its core technology stack combines proprietary BrainHearing algorithms, AI-powered speech processing, and the Oticon Kaizn personalization engine, with recent launches (Oticon Zeal and Oticon Intent) introducing the world's first Google Fast Pair hearing aid connectivity and Auracast-compatible wireless audio.
The business model blends hardware unit sales (hearing aids and diagnostic instruments) with professional services revenue through owned retail clinics and B2B distribution to audiologists and healthcare systems. Products are sold at quote-based pricing across premium to entry-level tiers via professional channels, with the majority of ownership held by the William Demant Foundation (~55-60%) providing long-term strategic stability. Recent strategic actions include divesting the Oticon Medical cochlear implant business and the EPOS enterprise headset unit to sharpen focus on hearing aids, diagnostics, and clinic-based hearing care, while investing in AI-differentiated product launches that have driven sharp recent stock performance.
Demant firmographics
Firmographics- Name
- Demant
- Legal name
- Demant A/S
- Website
- https://demant.com
- Company type
- Public
- Founded year
- 1904
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Demant is a Danish-founded (1904) global hearing healthcare group operating hearing aids (Oticon, Bernafon, Sonic), hearing care clinics (Audika), and diagnostic instruments (Interacoustics, Maico) across 130+ countries, serving hearing-impaired consumers and audiology professionals with AI-powered solutions.
- Ownership category
- akta.pro rank
Demant industry classification
Industry- Product category
- Hearing Healthcare
- NAICS
- Surgical and Medical Instrument Manufacturing (339112), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451), Medical Equipment and Supplies Manufacturing (3391), Audio and Video Equipment Manufacturing (33431)
- SIC
- Surgical & Medical Instruments & Apparatus (3841), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)
- akta.pro primary industry
- Hearing Enhancement / Assistive Listening Audio Devices (CRACANAL)
Keywords
Where Demant is headquartered
LocationHeadquarters
- HQ city
- Smørumnedre
- HQ country
- Denmark
- HQ region
- Europe
Offices5 records
Markets served
Demant business model
Business model- GTM type
- B2B and B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Operations, Technology or R&D, Supply Chain, Marketing or Sales, Infrastructure
Revenue model
- Hearing Aids: Development, manufacturing and sale of hearing aids and hearing instruments under multiple brands including Oticon, Bernafon, Sonic, and Philips. Revenue generated through retail clinics, audiologists, and direct consumer sales. Products range from entry-level to premium AI-powered devices.
- Hearing Care: Operation of hearing care clinics providing professional hearing care services, hearing tests, fitting, and aftercare. Services delivered through global network of hearing care professionals and clinics under brands including Audika.
- Diagnostics: Development and sale of diagnostic instruments and audiological equipment under brands including Interacoustics and Maico. Includes equipment for hearing assessment, newborn hearing screening, and hearing aid fitting.
- Professional Audio Equipment: Enterprise and gaming headset solutions under EPOS brand, serving professional communications markets.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | One time/ perpetual license | Premium AI-powered hearing aids with advanced features |
| Unit Pricing | One time/ perpetual license | Multi-brand hearing instrument portfolio |
Go-to-market motion3 records
Distribution channels4 records
Marketing channels6 records
Demant product offering
Product offeringCore offering
Demant designs, manufactures, and sells hearing aids (under the Oticon, Bernafon, Sonic, and Philips Hearing Solutions brands), clinical diagnostic instruments for audiology and balance (Interacoustics, MAICO), and operates hearing care retail clinics worldwide (Audika). It is a vertically integrated hearing healthcare company spanning devices, clinical diagnostics, fitting software, and in-clinic patient services.
Product overview
Demant is a global hearing healthcare and audio technology group operating three business areas: Hearing Aids (including Oticon, Bernafon, and Sonic hearing aid brands plus Philips-branded hearing solutions), Hearing Care (through Audika clinic network), and Diagnostics (Interacoustics and Maico diagnostic instruments). The company develops, manufactures, and sells hearing aids, cochlear implants, diagnostic equipment, and hearing care services. Oticon Zeal and Oticon Intent represent the latest AI-powered hearing aid launches featuring advanced sound processing and Google Fast Pair connectivity. The Diagnostics division offers Interacoustics audiometric equipment and Maico newborn screening solutions. The Oticon Medical cochlear implant business was divested to Cochlear Limited in May 2024.
Differentiator
Problem solved
Functional benefit
Brands
- Oticon: Flagship hearing aid brand of Demant, known for AI-powered hearing solutions including Oticon Zeal and Oticon Intent.
- Bernafon
- Sonic
- Audika
- Interacoustics
- MAICO
Products and services
- Oticon Intent Premium flagship hearing aid using BrainHearing technology with 4D sensors that adapt to the wearer's listening intentions, aimed at users with mild-to-profound hearing loss fitted by audiologists.
- Oticon Own SI Custom-molded invisible-in-the-canal hearing aid built on the Sirius platform with BrainHearing AI processing, targeting users seeking discretion.
- Oticon Real Hearing aid featuring BrainHearing technology and an on-board deep neural network trained on real-world sounds to preserve speech while reducing unwanted noise.
- Oticon Kaizn AI-driven mobile app that learns a hearing aid user's sound preferences over time and automatically customizes hearing aid settings, sold as part of the Oticon app suite.
- Oticon Companion App Unified mobile control and remote-care app for Oticon hearing aids, including remote fitting support and AI personalization.
- Bernafon Alpha XT Mid-to-premium hearing aid from the Bernafon brand using Bernafon's Hybrid Technology for sound processing.
- Sonic Radiant series Hearing aids under the Sonic brand aimed at value-conscious professional dispensing channels.
- Philips Hearing Solutions (HearLink 50) Philips-branded hearing aids produced by Demant under license and sold through selected retail and clinical channels.
- Interacoustics clinical diagnostic instruments
Quantifiable outcome
- Demant's new AI-powered hearing aid drove stock up 39% since early April 2026, marking best quarterly performance since 2000
- +3 more outcomes
Companies that use Demant
Customer profileNamed customers3 records
Segments3 records
Ideal customer profiles3 records
Demant technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration3 records
AI capability5 records
Feature7 records
Demant partnerships and signals
Strategic signalPartnerships
Five partnerships are on record, tiered minor and core.
- PitcherminorPitcher announced customer partnership with Demant to support commercial enablement across regulated industries, representing continued adoption of Pitcher's sales enablement platform in healthcare sector.
- ACCO Brands CorporationminorACCO Brands Corporation acquired EPOS from Demant for $11.7 million (including up to $3.5 million in deferred payments), expanding ACCO Brands' Kensington portfolio into premium enterprise headset market with EPOS's approximately $80 million annual revenue.
- GooglecoreOticon announced the world's first hearing aids with Google's Fast Pair technology, providing enhanced connectivity with Android devices. The new products Oticon Intent and Oticon Zeal feature advanced AI and discreet design with phased global availability.
- Cochlear LimitedcoreCochlear Limited, Australian hearing technology firm, acquired Oticon Medical (the cochlear implant division of Demant A/S) for an undisclosed sum in May 2024, a strategic move to expand Cochlear's scale, accelerate R&D, and integrate Oticon Medical's approximately 20,000 users.
- PhilipscoreDemant partnered with Philips to bring Philips-branded hearing solutions to the global market, combining Demant's world-leading hearing aid technology with Philips' global brand presence in healthcare to enrich the hearing healthcare experience.
Scale indicators12 records
Recent moves8 records
Expansion highlights6 records
Demant competitors and assessment
Company assessmentEmerging players
- Nuheara Limited: Australian-listed company producing smart hearing buds (e.g., IQbuds) that overlap with Demant's hearable/wellness category. Adjacent peer in the consumer-direct and OTC hearing enhancement segment.
- Bose Corporation: Entered the OTC hearing aid category after FDA rule changes, competing with Demant in the consumer-direct channel. Represents the competitive threat of OTC disintermediation that could erode Demant's professional channel economics.
- Cochlear Limited: Australian leader in cochlear implants that acquired Demant's Oticon Medical business in May 2024. While cochlear implants are a distinct category, the acquisition makes Cochlear a directly adjacent peer for the implantable hearing loss segment Demant has now exited.
- Eargo, Inc. US-based DTC/OTC hearing aid company focused on virtually invisible in-canal devices. Comparable to Demant in miniaturization technology and overlapping with Oticon Zeal's 'discreet in-the-ear' positioning, though serving a different channel.
- MED-EL: Austria-based manufacturer of cochlear implants and hearing implant systems. Comparable as an adjacent player in implantable hearing solutions and a technology partner in Bluetooth LE connectivity for hearing implants.
Direct peers
- Starkey Hearing Technologies: US-based hearing aid manufacturer (Starkey, NuEar) competing head-to-head with Oticon, particularly in the US professional channel. Notable for AI-focused product launches (e.g., Genesis AI) that compete directly with Oticon Zeal/Intent.
- WS Audiology: Owner of Widex and Sivantos (Signia) brands, formed from the Sivantos-Widex merger. A direct hearing aid competitor with comparable premium product positioning, R&D scale, and global distribution in hearing instruments.
- Sonova Holding AG: Swiss-based global hearing aid manufacturer (Phonak, Unitron, Hansaton brands) and the closest direct competitor to Demant's Oticon/Bernafon/Sonic business. Operates in hearing aids, cochlear implants (Advanced Bionics), and hearing care retail, overlapping with Demant across nearly every product and channel.
- GN Store Nord / GN Hearing: Danish-listed peer competing directly with Demant in hearing aids (ReSound, Beltone, Jabra) and a key rival in the hearing care oligopoly. Comparable in scale, geographic footprint, and channel mix across audiologists, retail, and OTC.
Others
- William Demant Foundation (parent): Holds ~59% of Demant A/S through William Demant Invest A/S; while not a product peer, it is the controlling shareholder and key ecosystem party that determines Demant's long-term capital allocation and strategic direction.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Demant social profiles
Digital presenceDemant compliance and trust
Trust signalCompliance4 records
Demant financial estimates
Financial estimateRevenue estimate
Valuation estimate
Demant leadership team
Management profileNumber of profiles
Profiles6 records
Demant subsidiaries and ownership
Company hierarchySubsidiaries5 records
Demant funding detail
Funding detailFunding overview
Funding rounds2 records
Investors2 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Demant M&A and investment
M&A and investmentM&A6 records
Investments3 records
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Demant
What does Demant do?
Demant designs, manufactures, and sells hearing aids (under the Oticon, Bernafon, Sonic, and Philips Hearing Solutions brands), clinical diagnostic instruments for audiology and balance (Interacoustics, MAICO), and operates hearing care retail clinics worldwide (Audika). It is a vertically integrated hearing healthcare company spanning devices, clinical diagnostics, fitting software, and in-clinic patient services.
Is Demant a public or private company?
Demant is a public company. It is classified as public and is currently operating.
When was Demant founded?
Demant was founded in 1904. It employs 11 to 50 people.
Where is Demant based?
Demant is headquartered in Smørumnedre, Denmark, in the Europe region.
How does Demant make money?
Four revenue lines are on record. Hearing Aids are the primary driver. The others are hearing Care, diagnostics and professional Audio Equipment.
Who are Demant's main competitors?
Emerging players on record are Nuheara Limited, Bose Corporation, Cochlear Limited, Eargo, Inc. and MED-EL. Direct peers are Starkey Hearing Technologies, WS Audiology, Sonova Holding AG and GN Store Nord / GN Hearing. William Demant Foundation (parent) is listed as an others.
Does Demant have an API?
No public API is recorded for Demant.
What industry is Demant in?
Demant's product category is Hearing Healthcare. Its primary akta.pro industry code is CRACANAL, Hearing Enhancement / Assistive Listening Audio Devices. Its NAICS code is 339112 and its SIC code is 3841.